APA (7th ed.) Citation

Paik, P. K., Felip, E., Veillon, R., Sakai, H., Cortot, A. B., Garassino, M. C., . . . Le, X. (2020). Tepotinib in non-small-cell lung cancer with MET Exon 14 skipping mutations. The New England journal of medicine, 3838, . https://doi.org/10.1056/NEJMoa2004407

Chicago Style (17th ed.) Citation

Paik, Paul K., et al. "Tepotinib in Non-small-cell Lung Cancer with MET Exon 14 Skipping Mutations." The New England Journal of Medicine 3838 (2020). https://doi.org/10.1056/NEJMoa2004407.

MLA (9th ed.) Citation

Paik, Paul K., et al. "Tepotinib in Non-small-cell Lung Cancer with MET Exon 14 Skipping Mutations." The New England Journal of Medicine, vol. 3838, 2020, https://doi.org/10.1056/NEJMoa2004407.